On April 3rd, the Centers for Medicare and Medicaid Services (CMS) released the 2018 Rate Announcement and Call Letter, implementing policy and payment updates for Medicare Advantage (MA) and Part D prescription drug plans for calendar year 2018. As part of the Final Call Letter, CMS issued a Request for Information (RFI) seeking recommendations on changes to MA or Part D that could encourage innovation and beneficiary choice.
The attachment summarizes major provisions of the final rule. The Final Call Letter is available here.
CMS will accept comments on the RFI at PartCDcomments@cms.hhs.gov until April 24, 2017. Commenters should include “2017 Transformation Ideas” in the email subject line.